Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,000
Closed -$183K 6158
2023
Q1
$183K Buy
+20,000
New +$256K ﹤0.01% 5205
2021
Q2
Sell
-4,000
Closed -$272K 6558
2021
Q1
$272K Buy
+4,000
New +$311K ﹤0.01% 5287
2019
Q4
Sell
-10,000
Closed -$226K 4239
2019
Q3
$226K Buy
+10,000
New +$277K ﹤0.01% 3729

Other funds holding CDNA

Israel Englander's CDNA Position: Q2 2026 in Review

Israel Englander opened a new position in CareDx (CDNA) in Q2 2026: 73,809 shares worth $2.1M. The stake represents ﹤0.01% of the portfolio and ranks #3778 among its holdings. This is a return to the name: Israel Englander previously reported a position in CDNA as recently as Q4 2025.

Israel Englander first reported a position in CDNA in Q4 2017 and has held it in 34 quarters since. The position peaked at $49.8M in Q2 2021. 225 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Israel Englander held 73,809 shares of CareDx worth $2.1M as of Q2 2026.
  • CareDx was a new Israel Englander position in Q2 2026.
  • CareDx made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3778 holding.
  • Israel Englander first reported a position in CareDx in Q4 2017 and has held it in 34 quarters since.
  • Israel Englander's CareDx position peaked at $49.8M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.